Schwartz GK - Search Results

1

Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.

Surriga O, Rajasekhar VK, Ambrosini G, Dogan Y, Huang R, Schwartz GK. Surriga O, et al. Among authors: schwartz gk. Mol Cancer Ther. 2013 Dec;12(12):2817-26. doi: 10.1158/1535-7163.MCT-13-0499. Epub 2013 Oct 18. Mol Cancer Ther. 2013. PMID: 24140933

2

Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells.

Motwani M, Sirotnak FM, She Y, Commes T, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Cancer Res. 2002 Jul 15;62(14):3950-5. Cancer Res. 2002. PMID: 12124325

3

Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.

Motwani M, Rizzo C, Sirotnak F, She Y, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Mol Cancer Ther. 2003 Jun;2(6):549-55. Mol Cancer Ther. 2003. PMID: 12813134

4

A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas.

Maki RG, Kraft AS, Scheu K, Yamada J, Wadler S, Antonescu CR, Wright JJ, Schwartz GK. Maki RG, et al. Among authors: schwartz gk. Cancer. 2005 Apr 1;103(7):1431-8. doi: 10.1002/cncr.20968. Cancer. 2005. PMID: 15739208 Free article. Clinical Trial.

5

Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells.

Sambol EB, Ambrosini G, Geha RC, Kennealey PT, Decarolis P, O'connor R, Wu YV, Motwani M, Chen JH, Schwartz GK, Singer S. Sambol EB, et al. Among authors: schwartz gk. Cancer Res. 2006 Jun 1;66(11):5858-66. doi: 10.1158/0008-5472.CAN-05-2933. Cancer Res. 2006. PMID: 16740725

6

Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.

Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Oncogene. 2007 May 24;26(24):3473-81. doi: 10.1038/sj.onc.1210136. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146434

7

Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.

Singer S, Socci ND, Ambrosini G, Sambol E, Decarolis P, Wu Y, O'Connor R, Maki R, Viale A, Sander C, Schwartz GK, Antonescu CR. Singer S, et al. Among authors: schwartz gk. Cancer Res. 2007 Jul 15;67(14):6626-36. doi: 10.1158/0008-5472.CAN-07-0584. Cancer Res. 2007. PMID: 17638873

8

The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner.

Ambrosini G, Seelman SL, Qin LX, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Cancer Res. 2008 Apr 1;68(7):2312-20. doi: 10.1158/0008-5472.CAN-07-2395. Cancer Res. 2008. PMID: 18381438

9

Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.

Ambrosini G, Cheema HS, Seelman S, Teed A, Sambol EB, Singer S, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Mol Cancer Ther. 2008 Apr;7(4):890-6. doi: 10.1158/1535-7163.MCT-07-0518. Mol Cancer Ther. 2008. PMID: 18413802 Free PMC article.

10

Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway.

Coward J, Ambrosini G, Musi E, Truman JP, Haimovitz-Friedman A, Allegood JC, Wang E, Merrill AH Jr, Schwartz GK. Coward J, et al. Among authors: schwartz gk. Autophagy. 2009 Feb;5(2):184-93. doi: 10.4161/auto.5.2.7361. Epub 2009 Feb 6. Autophagy. 2009. PMID: 19098447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters